Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
Ingrid L. Scully(Pfizer (United States)), Annaliesa S. Anderson(Pfizer (United States))
Cited by 47
Related Papers
A Novel <i>Staphylococcus aureus</i> Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine <i>S. aureus</i> Sepsis Model
|Infection and Immunity|2006|258